BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37410031)

  • 1. Scarring and Dyschromias in Fitzpatrick Skin Type IV-VI: A Review of Dermatologic Treatment Protocols.
    Bourgeois J; Beer J; Jacob L; Henry M
    J Drugs Dermatol; 2023 Jul; 22(7):7253. PubMed ID: 37410031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scarring and Dyschromias in Fitzpatrick Skin Type IV-VI: A Review of Dermatologic Treatment Protocols.
    Bourgeois J; Beer J; Jacob L; Henry M
    J Drugs Dermatol; 2023 Mar; 22(3):288-296. PubMed ID: 36877886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights on keloids, hypertrophic scars, and striae.
    Ud-Din S; Bayat A
    Dermatol Clin; 2014 Apr; 32(2):193-209. PubMed ID: 24680006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperplastic scars and keloids. Part I: basics and prevention].
    Baisch A; Riedel F
    HNO; 2006 Nov; 54(11):893-904; quiz 905. PubMed ID: 17041777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified Fitzpatrick Scale-Skin Color and Reactivity.
    Santiago S; Brown R; Shao K; Hooper J; Perez M
    J Drugs Dermatol; 2023 Jul; 22(7):641-646. PubMed ID: 37410041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating Scars in the Auricle Region.
    Watson D; Panuganti B
    Facial Plast Surg Clin North Am; 2017 Feb; 25(1):73-81. PubMed ID: 27888895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic scars and keloids.
    Haverstock BD
    Clin Podiatr Med Surg; 2001 Jan; 18(1):147-59. PubMed ID: 11344975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
    Ogawa R; Akaishi S
    Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of excessive dermal scarring.
    Roseborough IE; Grevious MA; Lee RC
    J Natl Med Assoc; 2004 Jan; 96(1):108-16. PubMed ID: 14746360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling Inflammation Pre-Emptively or at the Time of Cutaneous Injury Optimises Outcome of Skin Scarring.
    Ud-Din S; Bayat A
    Front Immunol; 2022; 13():883239. PubMed ID: 35711461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-mesenchymal transition in the formation of hypertrophic scars and keloids.
    Yuan FL; Sun ZL; Feng Y; Liu SY; Du Y; Yu S; Yang ML; Lv GZ
    J Cell Physiol; 2019 Dec; 234(12):21662-21669. PubMed ID: 31106425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical applications of basic research that shows reducing skin tension could prevent and treat abnormal scarring: the importance of fascial/subcutaneous tensile reduction sutures and flap surgery for keloid and hypertrophic scar reconstruction.
    Ogawa R; Akaishi S; Huang C; Dohi T; Aoki M; Omori Y; Koike S; Kobe K; Akimoto M; Hyakusoku H
    J Nippon Med Sch; 2011; 78(2):68-76. PubMed ID: 21551963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
    Ogawa R
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward understanding scarless skin wound healing and pathological scarring.
    Karppinen SM; Heljasvaara R; Gullberg D; Tasanen K; Pihlajaniemi T
    F1000Res; 2019; 8():. PubMed ID: 31231509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Influences on Wound Healing and Hypertrophic-Keloid Scarring: A Review for Basic Scientists and Clinicians.
    Thomas A; Farah K; Millis RM
    Cureus; 2022 Mar; 14(3):e23503. PubMed ID: 35371887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing Risks of Facial Scarring.
    Hom DB; Bernstein JD
    Facial Plast Surg Clin North Am; 2023 May; 31(2):195-207. PubMed ID: 37001923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.
    Gauglitz GG; Korting HC; Pavicic T; Ruzicka T; Jeschke MG
    Mol Med; 2011; 17(1-2):113-25. PubMed ID: 20927486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keloids and Hypertrophic Scars.
    Knowles A; Glass DA
    Dermatol Clin; 2023 Jul; 41(3):509-517. PubMed ID: 37236718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical considerations in skin of colour: minimizing pathological scars.
    Obi EE
    Clin Exp Dermatol; 2022 Aug; 47(8):1429-1437. PubMed ID: 35187688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.
    Lee HJ; Jang YJ
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.